Reproductive Outcome of Women with 21-Hydroxylase-Deficient Nonclassic Adrenal Hyperplasia
Open accessThe DOI matches its Crossref record; 41 of the 46 references it cites were found in a registry or an index.
Abstract
CONTEXT: Because many women with 21-hydroxylase (21-OH)-deficient nonclassic adrenal hyperplasia (NCAH) carry at least one allele affected by a severe mutation of CYP21, they are at risk for giving birth to infants with classic adrenal hyperplasia (CAH). OBJECTIVE: Our objective was to determine the frequency of CAH and NCAH infants born to mothers with 21-OH-deficient NCAH. DESIGN AND SETTING: We conducted an international multicenter retrospective/prospective study. PATIENTS AND METHODS: The outcome of 203 pregnancies among 101 women with 21-OH-deficient NCAH was reviewed. The diagnosis of 21-OH-deficient NCAH was established by a basal or post-ACTH-stimulation 17-hydroxyprogesterone level of more than 10 ng/ml (30.3 nmol/liter). When possible, genotype analyses were performed to confirm CAH or NCAH in the offspring. RESULTS: Of the 203 pregnancies, 138 (68%) occurred before the mother's diagnosis of NCAH and 65 (32%) after the diagnosis. Spontaneous miscarriages occurred in 35 of 138 pregnancies (25.4%) before the maternal diagnosis of NCAH, and in only four of 65 pregnancies (6.2%) after the diagnosis (P < 0.002). Four (2.5%; 95% confidence interval, 0.7-6.2%) of the 162 live births were diagnosed with CAH. To date, 24 (14.8%; 95% confidence interval, 9.0-20.6%) children, 13 girls and 11 boys, have been diagnosed with NCAH. The distribution of NCAH children and their mothers varied significantly by ethnicity (P < 0.0001, for both). CONCLUSIONS: The risk of a mother with 21-OH-deficient NCAH for giving birth to a child affected with CAH is 2.5%; at least 14.8% of children born to these mothers have NCAH.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source doesn’t support the claim as written.
In the citing paper
“Both studies reported elevated miscarriage rates of ;25% in those not receiving GC and 6% in those exposed to GC.”
From Congenital Adrenal Hyperplasia Due to Steroid 21-Hydroxylase Deficiency: An Endocrine Society* Clinical Practice Guideline (2018) · cites this paper as [234]
Checked by a reasoning model — may be wrong.
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“However, in two retrospective analyses of children born to women with NCCAH, the risk was higher, at 1.5% to 2.5% (234, 235).”
From Congenital Adrenal Hyperplasia Due to Steroid 21-Hydroxylase Deficiency: An Endocrine Society* Clinical Practice Guideline (2018) · cites this paper as [234]
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“Second, optimizing mineralocorticoid treatment appears to improve fertility SW and SV patients (365,591,663), but the exact mechanism remains unknown.”
From Congenital Adrenal Hyperplasia—Current Insights in Pathophysiology, Diagnostics, and Management (2022) · cites this paper as [663]
Experimental — accuracy not yet measuredIn the citing paper
“GC treatment was given to induce fertility in 23% (234) and 42% (235) of cases.”
From Congenital Adrenal Hyperplasia Due to Steroid 21-Hydroxylase Deficiency: An Endocrine Society* Clinical Practice Guideline (2018) · cites this paper as [234]
In the citing paper
“Two retrospective studies of pregnancies among women with NCCAH found that the majority of pregnancies occurred prior to the mother's diagnosis of NCCAH (234, 235).”
From Congenital Adrenal Hyperplasia Due to Steroid 21-Hydroxylase Deficiency: An Endocrine Society* Clinical Practice Guideline (2018) · cites this paper as [234]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
CLINICAL ASSESSMENT OF BODY HAIR GROWTH IN WOMEN
FERRIMAN, D., & GALLWEY, J. D. (1961) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-21-11-1440 · Cited by 2,506 · cited 1×
“The degree of hirsutism was assessed using a modified FerrimanGallwey scoring method, and hirsutism was considered to be present when a score of at least 8 was evident (23, 24).”
MethodCongenital adrenal hyperplasia due to 21-hydroxylase deficiency*
White, P. C., & Speiser, P. W. (2000) · Endocrine Reviews · doi:10.1210/edrv.21.3.0398 · Cited by 1,432
Self-citationCongenital Adrenal Hyperplasia
(1987) · New England Journal of Medicine · doi:10.1056/nejm198711263172211 · Cited by 1,409
Self-citationCongenital adrenal hyperplasia
Speiser, P. W., & White, P. C. (2003) · New England Journal of Medicine · doi:10.1056/nejmra021561 · Cited by 1,405
Self-citationHirsutism: Implications, etiology, and management
Hatch, R., Rosenfield, R. L., Kim, M. H., & Tredway, D. (1981) · American Journal of Obstetrics and Gynecology · doi:10.1016/0002-9378(81)90746-8 · Cited by 1,014
Congenital Adrenal Hyperplasia due to 21-Hydroxylase Deficiency
White, P. C. (2000) · Endocrine Reviews · doi:10.1210/er.21.3.245 · Cited by 877
Genotyping steroid 21-hydroxylase deficiency: hormonal reference data
NEW, M. I., LORENZEN, F., LERNER, A. J., KOHN, B., OBERFIELD, S. E., POLLACK, M. S., DUPONT, B., STONER, E., LEVY, D. J., PANG, S., et al. (1983) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-57-2-320 · Cited by 624
High frequency of nonclassical steroid 21-hydroxylase deficiency
SPEISER, P. W., DUPONT, B. O., RUBINSTEIN, P., PIAZZA, A., KASTELAN, A., & NEW, M. I. (1986) · Obstetrical & Gynecological Survey · doi:10.1097/00006254-198604000-00017 · Cited by 523
Self-citation(2002) · Hormone Research in Paediatrics · doi:10.1159/000065490 · Cited by 458
Pang, S., Wallace, M. A., Hofman, L., Thuline, H. C., Dorche, C., Lyon, I. C. T., Dobbins, R. H., Kling, S., Fujieda, K., & Suwa, S. (1988) · Journal of Urology · doi:10.1016/s0022-5347(17)42164-1 · Cited by 392
Research works printed but not linked: 1
- Prader, 1954, Der genitalbefund beim pseudohermaphroditismus femininus des kongenitalen androgenitalen syndroms, Helvetica Paediatr Acta, 3, 231
Cited by
Items 101–171 of 171
Cui, X., & Li, P. (2024) · Reproductive Health · doi:10.1186/s12978-024-01874-2 · Cited by 4
“The risk of NC-21OHD in female offspring of women with classic 21-OHD is 1.4– 2.5%, while the risk of NC-21OHD in female offspring is as high as 14% [10, 11].”
InfluentialNonclassical Congenital Adrenal Hyperplasia and Pregnancy
Çuhacı, N., Aydın, C., Yeşilyurt, A., Pınarlı, F. A., Ersoy, R., & Çakır, B. (2015) · Case Reports in Endocrinology · doi:10.1155/2015/296924 · Cited by 4
“5%) and that at least 15% of offspring would have NC-CAH [15].”
BackgroundThe way toward adulthood for females with nonclassic congenital adrenal hyperplasia
Ntali, G., Charisis, S., Kylafi, C. F., Vogiatzi, E., & Michala, L. (2021) · Endocrine · doi:10.1007/s12020-021-02715-z · Cited by 4
“Infertility is reported in 12–22% of women and it may be an issue even in those with regular menstruation [57, 65, 66].”
BackgroundInfluentialAlla, A., Draoui, N., Rami, I., Rouf, S., Saadi, H., Kamaoui, I., & Latrech, H. (2022) · Annals of Medicine and Surgery · doi:10.1016/j.amsu.2022.103673 · Cited by 6
Hiperplasia adrenal congênita em mulheres adultas: manejo de antigos e novos desafios
Costa‐Barbosa, F. A., Silveira, M. T., & Kater, C. E. (2014) · Arquivos Brasileiros de Endocrinologia & Metabologia · doi:10.1590/0004-2730000002987 · Cited by 9
“Adicionalmente, relatos recentes demonstraram que o uso de GC nessas pacientes está associado a uma menor taxa de abortamento (10,48), enfatizando a importância da corticoterapia nas mulheres com a FNC que tenham a fertilidade comprometida.”
BackgroundHiperplasia congénita da suprarrenal não clássica – aspetos relevantes para a prática clínica
Azevedo, T., Martins, T., Lemos, M. C., & Rodrigues, F. (2014) · Revista Portuguesa de Endocrinologia Diabetes e Metabolismo · doi:10.1016/j.rpedm.2013.12.001 · Cited by 10
Hyperplasie congénitale des surrénales par déficit en 21-hydroxylase
Bachelot, A. (2019) · Elsevier eBooks · doi:10.1016/b978-2-294-75965-9.00012-x · Cited by 4
Fertility in congenital adrenal hyperplasia due to 21-hydroxylase deficiency: a review
Roszkowska, Z., Bobrowicz, M., Betlejewska, J., Hubska, J., Rak, B., & Ambroziak, U. (2025) · Frontiers in Endocrinology · doi:10.3389/fendo.2025.1682341 · Cited by 5
Tercer Consenso Argentino sobre Patologías endocrinológicas
Boquete, H. (2009) · Revista Argentina de Endocrinología y Metabolismo · Cited by 3
Polat, S., & Arslan, Y. K. (2022) · Journal of Clinical Research in Pediatric Endocrinology · doi:10.4274/jcrpe.galenos.2021.2021.0184 · Cited by 4
“The prevalence of asymptomatic carriers for the disease in the general population was estimated to range from 1:50 to as high as 1:16 (24) and even higher among Ashkenazi Jews, according to a single report (8).”
BackgroundCardiovascular Risk in Women With Nonclassical Congenital Adrenal Hyperplasia
Costa, F. C., Gomes, L. G., de Lima, T. M., Bortolotto, L. A., Costa‐Hong, V., Verardino, R. G. S., Rocha, M. D. S., Ueda, S. K. N., de Miranda, M. C., de Souza, H. P., et al. (2024) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgae155 · Cited by 3
Self-citationYoung, J., Tardy, V., de la Perrière, A. B., Bachelot, A., & Morel, Y. (2010) · Annales d Endocrinologie · doi:10.1016/j.ando.2009.12.010 · Cited by 3
Assessing the risk of having a child with classic 21-hydroxylase deficiency: a new paradigm
Ilany, J., & Cohen, O. (2021) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2021.04.007 · Cited by 3
Caring for Patients With Congenital Adrenal Hyperplasia Throughout the Lifespan
Zwayne, N., Chawla, R., & van Leeuwen, K. D. (2023) · Obstetrics and Gynecology · doi:10.1097/aog.0000000000005263 · Cited by 3
Practise Updates: Diagnosis and Management of Idiopathic Hirsutism
Khare, V. R., Sinha, B., Sengupta, N., Chatterjee, S., Maji, D., Majumder, A., Guha, P., Datta, S., Hawelia, D. K., Bhattacharyya, S., et al. (2024) · Indian Journal of Endocrinology and Metabolism · doi:10.4103/ijem.ijem_2_24 · Cited by 8
“[34] 3.”
Hyperplasie congénitale des surrénales par déficit en 21-hydroxylase
Bachelot, A. (2012) · Elsevier eBooks · doi:10.1016/b978-2-294-70154-2.00012-1 · Cited by 4
Genetics and Pathophysiology of Congenital Adrenal Hyperplasia
Witchel, S. F. (2017) · Contemporary Endocrinology · doi:10.1007/978-3-319-62470-9_5 · Cited by 4
Self-citationHypertrichose diffuse révélant une hyperplasie congénitale des surrénales de forme non classique
Berthin, C., Sibilia, P., Martins-Héricher, J., Donzeau, A., & Martin, L. (2018) · Annales de Dermatologie et de Vénéréologie · doi:10.1016/j.annder.2018.02.003 · Cited by 3
Congenital adrenal hyperplasia
Krone, N. P. (2011) · doi:10.1093/med/9780199235292.003.0616 · Cited by 3
Xia, Y., Yu, F., Bai, Y., Jiang, L., Shi, P., Jiang, Z., & Kong, X. (2024) · Orphanet Journal of Rare Diseases · doi:10.1186/s13023-024-03414-4 · Cited by 2
“Previous studies have shown that the risk of an NC-CAH patient having a child with classic CAH is 1 to 2% [38, 39]; thus, it is essential to genotype the partners of patients with a severe mutation to predict the risk of classical CAH offspring and offer preconception genetic counselling.”
BackgroundCarrière, C., Sarfati, C., Téjédor, I., Dulon, J., Chakhtoura, Z., Courtillot, C., & Bachelot, A. (2022) · Annales d Endocrinologie · doi:10.1016/j.ando.2022.04.007 · Cited by 3
Osinovskaya, N. S., Glavnova, O. B., Yarmolinskaya, M. I., Sultanov, I. Y., Klyuchnikov, D. Y., Tkachenko, N. N., Nasykhova, Y. A., & Glotov, A. S. (2022) · Journal of obstetrics and women s diseases · doi:10.17816/jowd108963 · Cited by 2
Podgórski, R., Podgórska, D., & Sumińska, M. (2023) · Pediatria Polska · doi:10.5114/polp.2023.133534 · Cited by 2
Legro, R. S. (2007) · Springer eBooks · doi:10.1007/978-0-387-69248-7_2 · Cited by 2
“this diagnosis has a different prognosis, a different treatment regimen, and requires genetic counseling regarding the risks of congenital transmission [36, 37 ].”
BackgroundSuccessful pregnancy and delivery of a patient with congenital adrenal hyperplasia
Mun, D. H., Yun, H. N., Kim, J. W., Kim, Y.-H., & Song, T.-B. (2016) · Obstetrics & Gynecology Science · doi:10.5468/ogs.2016.59.1.50 · Cited by 2
“Infertility is comparative in NCCAH, though there is a higher occurrence of spontaneous miscarriage [3].”
BackgroundBüyükgebiz, A. (2007) · Journal of Pediatric Endocrinology and Metabolism · doi:10.1515/jpem.2007.20.4.473 · Cited by 2
Maimaitiming, J., Amuti, G., Tuhuti, A., Chen, Y., Song, X., Wang, J., Alimu, A., Zhang, K., Abudounaiyimu, M., Jiang, J., et al. (2021) · Pharmacogenomics and Personalized Medicine · doi:10.2147/pgpm.s297607 · Cited by 1
Pignatelli, D., & Pereira, S. S. (2021) · Springer eBooks · doi:10.1007/978-3-030-82591-1_2 · Cited by 1
Self-citationAnaforoğlu, İ. (2021) · Springer eBooks · doi:10.1007/978-3-030-82591-1_5 · Cited by 1
Ilia, G. M., Paltoglou, G., Chatzakis, C., CHRISTOPOULOS, P. F., Tzitiridou‐Chatzopoulou, M., & Mastorakos, G. P. (2024) · Endocrine · doi:10.1007/s12020-024-04023-8 · Cited by 2
Anaforoğlu, İ., & Ertörer, M. E. (2026) · HORMONES · doi:10.1007/s42000-026-00808-w · Cited by 1
The Impact of Genetic Steroid Disorders on Human Fertility
Reichman, D. E., & Rosenwaks, Z. (2013) · Elsevier eBooks · doi:10.1016/b978-0-12-416006-4.00027-2 · Cited by 1
de Vries, L., Baum, M., Horovitz, M., Phillip, M., Barash, G., Pinhas‐Hamiel, O., & Lazar, L. (2021) · Endocrine Practice · doi:10.1016/j.eprac.2021.08.005 · Cited by 3
Fertility Treatment in Women with Classical and Nonclassical Congenital Adrenal Hyperplasia
Olga, P., & Kolibianakis, E. M. (2021) · Springer eBooks · doi:10.1007/978-3-030-82591-1_8 · Cited by 2
Nácul, A. P., Silva, A. C. J. D. S. R. E., Yela, D. A., de Medeiros, S. F., Soares, J. M., Rezende, G. P., Damásio, L. C. V. D. C., Maranhão, T. M. D. O., Maciel, G. A. R., & Benetti‐Pinto, C. L. (2024) · Femina · doi:10.61622/rbgo/2024fps11 · Cited by 2
“(21) Furthermore, previous studies demonstrate that the risk of miscarriage decreased by more than 70% after diagnosis of the disease and initiation of treatment with glucocorticoids, going from 26% to 6% (23,24) (Level of Evidence C).”
Diagnosis and Management of Congenital Adrenal Hyperplasia
Dhesi, A. S., & McGovern, P. G. (2014) · Postgraduate Obstetrics & Gynecology · doi:10.1097/01.pgo.0000450250.49010.9e · Cited by 1
Congenital Adrenal Hyperplasia – The Main Effect of 21-Hydroxylase Deficiency
Carvalho, B., Carvalho, F., & Carvalho, D. M. (2024) · IntechOpen eBooks · doi:10.5772/intechopen.107092 · Cited by 1
Endocrine disease in pregnancy
Nelson, C., & Germain, S. (2011) · doi:10.1093/med/9780199235292.003.0936 · Cited by 1
Mesa 3: Hiperplasia Adrenal Congenita en Adolescentes y Adultos
Alba, L. G., Colombi, L., Cross, G., Leiderman, S. M., & Pasqualini, T. (2009) · Revista Argentina de Endocrinología y Metabolismo
Infertilidad femenina de origen endocrino
Robin, G., Ferté-Delbende, C., Proust-Richard, C., Karouz, W., Dewailly, D., & Catteau-Jonard, S. (2012) · EMC - Ginecología-Obstetricia · doi:10.1016/s1283-081x(12)63398-0
Self-citationLow-dose ACTH test for the diagnosis of non-classical form of congenital adrenocortical dysfunction
Chagay, N. B., Fadeev, V. V., & Бакулина, Е. Г. (2010) · Problems of Endocrinology · doi:10.14341/probl201056210-14
Infertilités féminines d’origine endocrinienne
Robin, G., Ferté-Delbende, C., Proust-Richard, C., Karouz, W., Dewailly, D., & Catteau-Jonard, S. (2012) · EMC - Gynécologie · doi:10.1016/s0246-1064(12)54741-9 · Cited by 2
Self-citationReisch, N., & Reincke, M. (2012) · Der Gynäkologe · doi:10.1007/s00129-011-2904-6
Term Infant With Ambiguous Genitalia
Pimentel, J. L., Castellanos, L., Gonzalez, M., Febres, R. J., Khanna, S., & Dave-Sharma, S. (2013) · NeoReviews · doi:10.1542/neo.14-10-e539
Franik, G., & Skałba, P. (2011) · PubMed · Cited by 1
Androgenic Disorders and Abnormal Pubertal Development
Speiser, P. (2016) · Springer eBooks · doi:10.1007/978-3-319-27225-2_6
“It is important to note that pregnancy is achieved spontaneously in most cases, but that there may be subfecundity in the pregnancies achieved without glucocorticoid treatment [ 10 , 11 ].”
BackgroundSelf-citationNichtklassisches adrenogenitales Syndrom: Diagnose und Therapie
Böttcher, B., & Wildt, L. (2016) · Gynäkologische Endokrinologie · doi:10.1007/s10304-016-0088-9
“Unter dieser Therapie ist zudem eine verminderte Rate an Fehlgeburten in diesem Patientinnenkollektiv beschrieben worden [3, 13].”
BackgroundDie Genetik der In(Sub)fertilität
Tramontana, A. (2017) · Journal für Gynäkologische Endokrinologie/Schweiz · doi:10.1007/s41975-017-0019-8
Fertility and Pregnancy in Patients With 21-Hydroxylase Deficiency
Grouthier, V., Courtillot, C., Dulon, J., Touraine, P. A., & Bachelot, A. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-801238-3.65342-4
21-hydroxylase deficiency and fertility
Amiraslanova, M. M., & Kuznetsova, I. V. (2020) · Medical alphabet · doi:10.33667/2078-5631-2020-4-16-26
“Профилактика осложнений беременности у женщин с ВДКН Основным осложнением беременности у больных ВДКН является самопроизвольный выкидыш [38], причинами которого могут быть как гиперандрогенизм и гиполютеинизм, так и относительная недостаточность глюкокортикоидов.”
Late-Onset 21-Hydroxylase Deficiency
Igaz, P. (2021) · Springer eBooks · doi:10.1007/978-3-030-62011-0_34
Die Genetik der In(Sub)fertilität
Tramontana, A. (2017) · Journal für Gynäkologische Endokrinologie/Österreich · doi:10.1007/s41974-017-0015-7
Diagnostic Challenges in Nonclassical Congenital Adrenal Hyperplasia
Escobar-Morreale, H. F., & Luque‐Ramírez, M. (2021) · Springer eBooks · doi:10.1007/978-3-030-82591-1_4
Self-citationCarmina, E. (2021) · Springer eBooks · doi:10.1007/978-3-030-82591-1_6 · Cited by 2
Self-citation(2007) · Current Opinion in Obstetrics & Gynecology · doi:10.1097/gco.0b013e3282f0ffad
Adrenal Glands - The Current Stage and New Perspectives of Diseases and Treatment
Păun, D. L., Cianci, P., & Restini, E. (2022) · IntechOpen eBooks · doi:10.5772/intechopen.102209 · Cited by 1
Pepe, G., & Aversa, T. (2023) · L Endocrinologo · doi:10.1007/s40619-023-01252-3
Pregnancy in a woman with congenital adrenal hyperplasia: A case report and literature review
Zhu, Y. C., Li, C., Zhang, X., Zhang, X., & Zhang, L. (2023) · Gynecology and Obstetrics Clinical Medicine · doi:10.1016/j.gocm.2023.04.006
The impact of genetic steroid disorders on human fertility
Reichman, D. E., Rosenwaks, Z., Perelman, R. O., & Cohen, C. (2023) · Elsevier eBooks · doi:10.1016/b978-0-12-821424-4.00022-8
Disorders of Adrenal Steroid Biosynthesis Defects
He, X., & Auchus, R. J. (2024) · Elsevier eBooks · doi:10.1016/b978-0-12-822563-9.00216-x · Cited by 1
Le forme non classiche di iperplasia surrenalica congenita nella donna: diagnosi e terapia
Campioni, L., Carlo, M. C. D., Bergoglio, B., & Giordano, R. (2024) · L Endocrinologo · doi:10.1007/s40619-024-01515-7
“In oltre il 50% dei casi compare oligomenorrea, mentre nel 13% dei casi anovularietà cronica e conseguen-te difficoltà a concepire [10–13], per l’azione dell’iperan-drogenismo stesso sull’asse HPG. L’aspetto ecografico di ovaio policistico (PCOM) può inoltre essere presente con frequenza variabile a…”
Congenital Adrenal Hyperplasia
Witchel, S. F., Oberfield, S. E., Fisher, A. S., & Trapp, C. M. (2024) · Springer eBooks · doi:10.1007/978-3-031-66296-6_11
Self-citationFertility and pregnancy in patients with 21 hydroxylase deficiency
Grouthier, V., & Bachelot, A. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-13825-6.00207-7
Função reprodutiva em portadoras de hiperplasia adrenal congênita: revisão narrativa da literatura
Cristófalo, M. M., Andrade, S. G. D. A., Andrade, F. M., & Aldrighi, J. M. (2023) · Femina · doi:10.61622/0100-72545112202307
Alwani, M., Nimbalkar, P., Halvadia, H., Kadikar, B., & Kaku, Y. D. (2024) · doi:10.5005/jihr-11055-v1n1-11
Qiu, R., Yang, T., Shang, C., Zhu, W., & Zheng, F. (2026) · Diagnostics · doi:10.3390/diagnostics16020202
“Previous studies have indicated that patients with NC-21OHD typically exhibit a median basal 17-OHP level of 6–10 ng/mL, with post-ACTH stimulation levels usually exceeding 30 ng/mL [19–21].”
FERREIRA, B., Robin, G., Pigny, P., Bachelot, A., RIBIERE, L., & Catteau-Jonard, S. (2026) · Gynecological Endocrinology · doi:10.1080/09513590.2026.2659979
Gee, H., & Hearn, T. J. (2026) · BMJ connections. · doi:10.1136/bmjccgg-2026-000087
Reproductive and fertility challenges in adolescents with congenital adrenal hyperplasia
Tschaidse, L., Auer, M. K., Nowotny, H. F., & Reisch, N. (2026) · Frontiers in Adolescent Medicine · doi:10.3389/fradm.2026.1878713
“In a study by Casteras et al. (21), only 23.6% of women with classic CAH expressed a wish for pregnancy, whereas this proportion was closer to 50% in women with NCCAH (30, 33).”
InfluentialApproach to the patient: the pregnant woman with congenital adrenal hyperplasia
Reisch, N., Auer, M. K., Nowotny, H. F., Welp, A.-C., Dervishi, O., Rogenhofer, N., Thaler, C., & Tschaidse, L. (2026) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgag332
Szklarz, M., Wołos-Kłosowicz, K., Szulc, J., Górny, J. M., & Matuszewski, W. (2026) · Middle East Fertility Society Journal · doi:10.1186/s43043-026-00364-8
“Pregnancy in classic CAH carries increased risks of cesarean delivery, preeclampsia, eclampsia, gestational diabetes, hypertension, excessive weight gain, and mis-carriage, often requiring higher glucocorticoid doses [49–51].”
Metadata
- Authors
- Moran, C., Azziz, R., Weintrob, N., Witchel, S. F., Rohmer, V., Dewailly, D., Marcondes, J. A. M., Pugeat, M., Speiser, P. W., Pignatelli, D., Mendonca, B. B., Bachega, T. A. S., Escobar-Morreale, H. F., Carmina, E., Fruzzetti, F., & Kelestimur, F.
- Affiliations
- Mexican Institute of Social Security (C.M.), 06725 Mexico City, Mexico
- Cedars-Sinai Medical Center (US)
- Schneider Children's Medical Center (IL)
- Children's Hospital of Pittsburgh (US)
- Centre Hospitalier Universitaire d'Angers (FR)
- Centre Hospitalier Universitaire de Lille (FR)
- Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo (BR)
- Hospices Civils de Lyon (FR)
- Schneider Children's Hospital (US)
- Universidade do Porto (PT)
- Hospital Universitario Ramón y Cajal (ES)
- University of Palermo (IT)
- University of Pisa (IT)
- Erciyes University Medical School (F.K.), 3805 Kayseri, Turkey
- ORCID
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 2006-09-01
- Volume
- 91
- Issue
- 9
- Pages
- 3451-3456
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- OpenAlex
- W2001112976
- Cited by
- 174
- References
- 46
- Citations by year
- 2026: 7 · 2025: 4 · 2024: 15 · 2023: 9 · 2022: 14 · 2021: 13 · 2020: 8 · 2019: 12 · 2018: 8 · 2017: 9 · 2016: 10 · 2015: 7 · 2014: 6 · 2013: 7 · 2012: 9
- FWCI
- 2.16
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- The Journal of Clinical Endocrinology & Metabolism (publishedVersion)
- PubMed (publishedVersion)
- Nova Science Publishers (Nova Science Publishers, Inc.) (submittedVersion)
- INFM-OAR (INFN Catania) (submittedVersion, other-oa)
- Zenodo (CERN European Organization for Nuclear Research) (other-oa)
- Funders
- Cedars-Sinai Medical Center
- National Institutes of Health
- U.S. Public Health Service (K24-D01346)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Sexual Differentiation and Disorders
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
- Health Sciences › Medicine › Reproductive Medicine › Ovarian function and disorders
- Keywords
- 21-hydroxylase deficiency, CYP21, pregnancy outcomes, miscarriage, prenatal diagnosis, ethnic differences, genotype analysis, 17-hydroxyprogesterone
- MeSH terms
- Adrenal Hyperplasia, Congenital, Adult, Child, Preschool, Female, Genotype, Humans, Infant, Infant, Newborn, Male, Pregnancy, Prospective Studies, Retrospective Studies, Steroid 21-Hydroxylase, Prevalence
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.